Arbutus Biopharma Corp (ABUS) Free cash flow 2016–2025
Arbutus Biopharma Corp (ABUS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$39.6MFY2025 · since FY2016: -$61.9M → -$39.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.6M | +39.1% |
| FY2024 | -$65.0M | +25.2% |
| FY2023 | -$86.9M | -142.4% |
| FY2022 | -$35.9M | +47.5% |
| FY2021 | -$68.3M | -32.3% |
| FY2020 | -$51.7M | +27.8% |
| FY2019 | -$71.6M | -3.8% |
| FY2018 | -$69.0M | -23.4% |
| FY2017 | -$55.9M | +9.7% |
| FY2016 | -$61.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice